par Martel, Samuel;Maurer, Christian;Lambertini, Matteo 
;Pondé, Noam;de Azambuja, Evandro
Référence Expert opinion on drug safety, 16, 9, page (1021-1038)
Publication Publié, 2017-09
;Pondé, Noam;de Azambuja, Evandro Référence Expert opinion on drug safety, 16, 9, page (1021-1038)
Publication Publié, 2017-09
Article révisé par les pairs
| Titre: |
|
| Auteur: | Martel, Samuel; Maurer, Christian; Lambertini, Matteo; Pondé, Noam; de Azambuja, Evandro |
| Informations sur la publication: | Expert opinion on drug safety, 16, 9, page (1021-1038) |
| Statut de publication: | Publié, 2017-09 |
| Sujet CREF: | Pharmacologie |
| Mots-clés: | Anti-HER2 agents |
| breast cancer | |
| cardiac biomarkers | |
| cardiac imaging | |
| cardiac risk assessment | |
| cardiotoxicity | |
| CDK4/6 inhibitors | |
| chemotherapy | |
| endocrine therapy | |
| Note générale: | SCOPUS: re.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1474-0338 |
| info:doi/10.1080/14740338.2017.1351541 | |
| info:scp/85028670769 | |
| info:pmid/28697311 |
